Methods of using nucleic acid vector-lipid complexes
AssigneeNational Jewish Medical and Research Center
InventorsSteven W. Dow, Robyn E. Elmslie, Jurgen Karl Johannes Schwarze, Erwin W. Gelfand
Life of this patent
Estimating the term…
Abstract
This invention relates to a vaccine and a method for immune activation which is effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in a mammal. The method is particularly effective for protecting a mammal from a disease including cancer, a disease associated with allergic inflammation, an infectious disease, or a condition associated with a deleterious activity of a self-antigen. Also disclosed are therapeutic compositions useful in such a method.
Claims9
A method for eliciting a systemic, non-antigen-specific immune response in a mammal, comprising administering to said mammal an amount of a composition effective to elicit said immune response, wherein said composition comprises:
- a. a cationic liposome delivery vehicle;
- and
- b. an isolated nucleic acid molecule comprising an isolated bacterially-derived nucleic acid vector without a gene insert or a fragment thereof.
Dependencies are inferred from the claim text.